BRAINSTORM CELL THERAPUTC by BrainStorm Cell Therapeutics Inc. (BCLI) Stock Price Target 2026

See analyst price targets, ratings and recent upgrades and downgrades for BRAINSTORM CELL THERAPUTC by BrainStorm Cell Therapeutics Inc. (BCLI) stock.

Price Target Range —

Analyst Consensus — 1 Analysts

1Hold

# Analysts1

Rating Trend — Last 9 Months

Latest Upgrades and Downgrades for BRAINSTORM CELL THERAPUTC by BrainStorm Cell Therapeutics Inc. Stock

See all ratings →

Date	Firm	Analyst	Action	Rating Change	Price Target
Jul 23, 2025	Maxim Group	Jason McCarthy	Downgrade	Buy→Hold	—
Jul 11, 2024	Maxim Group	Jason McCarthy	Upgrade	Hold→Buy	$30

Analyst Ratings News

PRO
Maxim Group Downgrades Brainstorm Cell to Hold

Maxim Group analyst Jason McCarthy downgrades Brainstorm Cell (NASDAQ:BCLI) from Buy to Hold.

Benzinga Newsdesk

PRO
Maxim Group Upgrades Brainstorm Cell to Buy, Announces $2 Price Target

Maxim Group analyst Jason McCarthy upgrades Brainstorm Cell (NASDAQ:BCLI) from Hold to Buy and announces $2 price target.

Benzinga Newsdesk

Benzinga's Top Ratings Upgrades, Downgrades For September 28, 2023

Benzinga Insights

PRO
Maxim Group Downgrades Brainstorm Cell to Hold

Maxim Group analyst Jason McCarthy downgrades Brainstorm Cell (NASDAQ:BCLI) from Buy to Hold.

Benzinga Newsdesk

Maxim Group Maintains Buy Rating for Brainstorm Cell: Here's What You Need To Know

Benzinga Insights

PRO
Maxim Group Maintains Buy on Brainstorm Cell, Lowers Price Target to $10

Maxim Group analyst Jason McCarthy maintains Brainstorm Cell (NASDAQ:BCLI) with a Buy and lowers the price target from $5 to $10.

Benzinga Newsdesk

BRAINSTORM CELL THERAPUTC by BrainStorm Cell Therapeutics Inc.

BRAINSTORM CELL THERAPUTC by BrainStorm Cell Therapeutics Inc. (BCLI) Stock Price Target 2026

Latest Upgrades and Downgrades for BRAINSTORM CELL THERAPUTC by BrainStorm Cell Therapeutics Inc. Stock

Analyst Ratings News

PROMaxim Group Downgrades Brainstorm Cell to Hold

PROMaxim Group Upgrades Brainstorm Cell to Buy, Announces $2 Price Target

Benzinga's Top Ratings Upgrades, Downgrades For September 28, 2023

PROMaxim Group Downgrades Brainstorm Cell to Hold

Maxim Group Maintains Buy Rating for Brainstorm Cell: Here's What You Need To Know

PROMaxim Group Maintains Buy on Brainstorm Cell, Lowers Price Target to $10

PRO
Maxim Group Downgrades Brainstorm Cell to Hold

PRO
Maxim Group Upgrades Brainstorm Cell to Buy, Announces $2 Price Target

PRO
Maxim Group Downgrades Brainstorm Cell to Hold

PRO
Maxim Group Maintains Buy on Brainstorm Cell, Lowers Price Target to $10